Our partnership with Gilead Sciences, Inc. will be joining forces with Siemens Healthineers to offer the Enhanced Liver Fibrosis (ELF™)
Together, will test over 30,000 qualifying study participants by 2023 for risk of cirrhosis and liver-related illnesses.
Read the press release here.
Recent Comments